基于JCI标准的高危药品管理在神经内科的应用分析  

Study on Management of High-alert Drug Based on JCI Standard in Neurology

作　　者：徐利萍 杨铭 邵微颖 XU Li-ping;YANG Ming;SHAO Wei-ying(Quzhou Hospital affiliated to Wenzhou Medical University/Quzhou People's Hospital)

机构地区：[1]温州医科大学附属衢州医院/衢州市人民医院

出　　处：《医院管理论坛》2022年第1期45-48,共4页Hospital Management Forum

摘　　要：目的观察基于JCI标准的高危药品管理在神经内科的应用效果。方法以2020年7月神经内科实施JCI标准的高危药品管理为分界线,将2019年6月—2020年6月实施常规管理为管理前组,将2020年7月—2021年7月实施基于JCI标准药品管理为管理后组,比较管理前后效果。结果与管理前组相比,管理后组医务人员对高危药品的认知水平提高(p<0.05),高危药品管理达标率提高(p<0.05),高危药品分类错误率及药品处方差错数均降低(p<0.05)。结论基于JCI标准的高危药品管理能明显提升神经内科高危药品管理质量。Objective To observe the effect of high-alert drug management based on JCI standard in department of neurology.Methods High-alert drug management based on JCI standard was initiated in department of neurology in July 2020.Routine management was implemented during June,2019 to 2020,which was taken as the pre-management group.The period of July,2020-2021 was the post-management group.The effects were compared between the groups.Results Compared with pre-management group,the cognition of medical staff on high-alert drugs improved(p<0.05),and the compliance rate of high-alert drug management increased(p<0.05),and wrong classification rate of high-alert drugs and the number of drug prescription errors decreased(p<0.05)in post-management group.Conclusion High-alert drug management based on JCI standard can significantly improve the quality of high-alert drug management in department of neurology.

关 键 词：JCI标准 高危药品 神经内科 

分 类 号：R197.3[医药卫生—卫生事业管理]